The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison
暂无分享,去创建一个
N. Pearce | A. Al-Chalabi | C. Shaw | D. Ståhl | M. Turner | P. Leigh | R. Burman | Sarah Martin | C. Ellis | D. Marchment | A. Kulka | L. Carroll | Keelan Shaw | Emma Trevor-Jones | S. Khan | Leah Mursaleen | Ammar Al-Chalabi | P. Leigh | Christopher E. Shaw | Sabyha Khan | Catherine E Ellis | Martin R. Turner | Deepti | Marchment | Neil | Pearce | A. Al-Chalabi | Martin R. Turner | Catherine E Ellis
[1] Sarah Martin,et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] Annelot M. Dekker,et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis , 2017 .
[3] A. Al-Chalabi,et al. A clinical tool for predicting survival in ALS , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[4] R. Rojas-García,et al. ALS: A bucket of genes, environment, metabolism and unknown ingredients , 2016, Progress in Neurobiology.
[5] O. Hardiman,et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[6] P. Shaw,et al. Gastrostomy use in motor neurone disease (MND): A review, meta-analysis and survey of current practice , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[7] P. Shaw,et al. The natural history of motor neuron disease: Assessing the impact of specialist care , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[8] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[9] E. Beghi,et al. Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[10] P. Shaw,et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial , 2006, The Lancet Neurology.
[11] G. Cumming,et al. Inference by eye: confidence intervals and how to read pictures of data. , 2005, The American psychologist.
[12] K. Talbot. Motor neuron disease , 2004, Practical Neurology.
[13] Afschin Gandjour,et al. Threshold Volumes Associated With Higher Survival in Health Care: A Systematic Review , 2003, Medical care.
[14] O. Hardiman,et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000 , 2003, Journal of neurology, neurosurgery, and psychiatry.
[15] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[16] H. Luft,et al. The volume-outcome relationship: practice-makes-perfect or selective-referral patterns? , 1987, Health services research.
[17] A. Dreher. Modeling Survival Data Extending The Cox Model , 2016 .
[18] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[19] E. Beghi,et al. ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy. , 2007, Journal of neurology.
[20] R. Miller,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[21] P. Grambsch,et al. A Package for Survival Analysis in S , 1994 .
[22] D. McFadden. Conditional logit analysis of qualitative choice behavior , 1972 .